Hong Kong Stock Movement | GenFleet Therapeutics-B (02595.HK) rises over 5% as GFH276 pancreatic cancer combination therapy study completes first patient dosing in China and overseas
Zhitong Finance APP has learned that GenFleet Therapeutics-B (02595.HK) rose more than 5% during intraday trading. As of press time, it was up 3.83% at HK$20.08, with a turnover of HK$10.9661 million.
Latest
1 m ago

